Sei Investments CO Intercept Pharmaceuticals, Inc. Transaction History

Sei Investments CO

$69 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$9.17 - $19.29 $213,101 - $448,280	-23,239 Reduced 67.17%	11,358 $125,000
Q1 2023 May 12, 2023	SELL	$12.53 - $21.71 $102,946 - $178,369	-8,216 Reduced 19.19%	34,597 $464,000
Q4 2022 Feb 10, 2023	BUY	$11.61 - $16.11 $497,058 - $689,717	42,813 New	42,813 $529,000
Q4 2020 Feb 08, 2021	SELL	$24.48 - $42.47 $1.66 Million - $2.87 Million	-67,609 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$39.09 - $53.44 $332,186 - $454,133	-8,498 Reduced 11.17%	67,609 $2.77 Million
Q2 2020 Aug 17, 2020	BUY	$46.7 - $92.04 $3.31 Million - $6.53 Million	70,962 Added 1379.24%	76,107 $3.61 Million
Q2 2020 Aug 11, 2020	BUY	$46.7 - $92.04 $15,177 - $29,913	325 Added 6.74%	5,145 $531,000
Q1 2020 May 14, 2020	SELL	$48.35 - $118.68 $231,113 - $567,290	-4,780 Reduced 49.79%	4,820 $279,000
Q4 2019 Feb 06, 2020	BUY	$57.36 - $124.1 $51,796 - $112,062	903 Added 10.38%	9,600 $1.19 Million
Q3 2019 Nov 12, 2019	BUY	$58.69 - $80.46 $128,648 - $176,368	2,192 Added 33.7%	8,697 $552,000
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $233,310 - $362,040	3,000 Added 85.59%	6,505 $497,000
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $278,336 - $365,781	3,031 Added 639.45%	3,505 $370,000
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $26,423 - $38,949	308 Added 185.54%	474 $40,000
Q3 2018 Nov 08, 2018	SELL	$88.49 - $127.55 $51,324 - $73,979	-580 Reduced 77.75%	166 $20,000
Q2 2018 Aug 03, 2018	BUY	$60.0 - $85.67 $4,320 - $6,168	72 Added 10.68%	746 $63,000
Q1 2018 May 11, 2018	BUY	$52.72 - $67.25 $4,797 - $6,119	91 Added 15.61%	674 $41,000
Q4 2017 Feb 08, 2018	SELL	$58.2 - $72.76 $4,947 - $6,184	-85 Reduced 12.72%	583 $34,000
Q3 2017 Nov 06, 2017	BUY	$57.01 - $118.75 $38,082 - $79,325	668	668 $39,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account